Influence of fourth generation poly(propyleneimine) Dendrimers on blood cells

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 11, 2012, Pages 2870-2880

  Ziemba, Barbara ^a   Halets, Inessa ^b   Shcharbin, Dzmitry ^b   Appelhans, Dietmar ^c   Voit, Brigitte ^c   Pieszynski, Ireneusz ^d   Bryszewska, Maria ^a   Klajnert, Barbara ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^c LEIBNIZ INSTITUTE OF POLYMER RESEARCH DRESDEN   (Germany)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Aggregation; Blood; Dendrimer; Glycodendrimer; Haemolysis; HSA; Lymphocytes; Platelets; Poly(propyleneimine); PPI; Proliferation; Red blood cells; Toxicity

Indexed keywords

AGGLOMERATION; BLOOD; CARBOHYDRATES; CELL PROLIFERATION; CELLS; DENDRIMERS; DYES; MEDICAL APPLICATIONS; PLATELETS; TOXICITY;

GLYCODENDRIMERS; HAEMOLYSIS; HSA; LYMPHOCYTES; POLY(PROPYLENE IMINE); PPI; PROLIFERATION; RED BLOOD CELL;

FUNCTIONAL POLYMERS;

DENDRIMER; HUMAN SERUM ALBUMIN; MALTOTRIOSE; OLIGOSACCHARIDE; POLY(PROPYLENEIMINE) G4 DS; POLY(PROPYLENEIMINE) G4 OS; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROGEN BOND; LYMPHOCYTE; MOLECULAR INTERACTION; NORMAL HUMAN; PLASMA; THROMBOCYTE AGGREGATION;

EID: 84869082119     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34222     Document Type: Article

References (66)

1. Tomalia DA, Baker H, Dewald JR, Hall M, Kallos G, Martin S, Roeck S, Ryder J, Smith P. A new class of polymers: Starburstdendric macromolecules. Polym J 1985;17:117-132.
2. Newkome GR, Yao ZQ, Baker GR, Gupta VK. Cascade molecules: a new approach to micelles, A[27]-Arborol. J Org Chem 1985;50:2003-2006.
3. Boas U, Heegaard PM. Dendrimers in drug research. Chem Soc Rev 2004;33:43-63. (Pubitemid 38376610)
4. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release 2000;65:133-148. (Pubitemid 30122922)
5. Bhadra D, Yadav AK, Bandra S, Jain NK. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int J Pharm 2005;295:221-223.
6. Bhadra D, Bhadra S, Jain NK. PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate. Pharm Res 2006;23:623-633.
7. Pedziwiatr-Werbicka E, Ferenc M, Zaborski M, Gabara B, Klajnert B, Bryszewska M. Characterization of complexes formed by polypropylene imine dendrimers and anti-HIV oligonucleotides. Colloids Surf B Biointerfaces 2011;83:360-366.
8. Lee H, Larson RG. Lipid bilayer curvature and pore formation induced by charged linear polymers and dendrimers: The effect of molecular shape. J Phys Chem B 2008;112:12279-12285.
9. Choi SH, Lee SH, Park TG. Temperature-sensitive pluronic/poly (ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment. Biomacromolecules 2006;7:1864-1870. (Pubitemid 43985108)
10. Wilbur D, Pathare P, Hamlin D, Bhular K, Vessela R. Biotin reagents for antibody pretargeting: synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconj Chem 1998;9:813-825. (Pubitemid 28542250)
11. Bhadra D, Bhadra S, Jain S, Jain NK. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm 2003;257:111-124. (Pubitemid 36507038)
12. Stasko NA, Johnson CB, Schoenfisch MH, Johnson TA, Holmuhamedov EL. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules 2007;8:3853-3859.
13. Namaji H, Adeli M. Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. Biomaterials 2005;26:1175-1183. (Pubitemid 39286827)
14. Agashe HB, Dutta T, Garg M, Jain NK. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer. J Pharm Pharmacol 2006;58:1491-1498. (Pubitemid 44785538)
15. Okuda T, Sugiyama A, Niidome T, Aoyagi H. Characters of dendritic poly (L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. Biomaterials 2004;25:537-544. (Pubitemid 37329706)
16. Kono K, Akiyama H, Takahashi T, Takagishi T, Harada A. Transfection activity of polyamidoamine dendrimers having hydrophobic amino acid residues in the periphery. Bioconj Chem 2005;16:208-214. (Pubitemid 40129695)
17. Klajnert B, Appelhans D, Komber H, Morgner N, Schwarz S, Richter S, Brutschy B, Ionov M, Tonkikh AK, Bryszewska M, Voit B. The influence of densely organized maltose shells on biological properties of poly (propylene imine) dendrimers: new effect dependent on hydrogen bonding. Chem Eur J 2008;14:7030-7041.
18. Fischer M, Appelhans D, Klajnert B, Bryszewska M, Voit B, Rogers M. The influence of surface functionality of poly (propylene imine) dendrimers on aggregation and propagation of the scrapie prion protein. Biomacromolecules 2010;11:1314-1325.
19. Klementieva O, Benseny-Cases N, Gella A, Appelhans D, Voit B, Cladera J. Dense shell glycodendrimers as potential non-toxic antiamyloidogenic agents in Alzheimer's disease-Amyloid-dendrimer aggregates morphology and cell toxicity. Biomacromolecules 2011;12:3903-3909.
20. Janaszewska A, Maczynska K, Matuszko G, Appelhans D, Voit B, Klajnert B, Bryszewska M. Cytotoxicity of PAMAM, PPI and maltose modified PPI dendrimers in Chinese hamster ovary (CHO) and human ovarian carcinoma (SKOV3) cells. New J Chem 2012;99:261-268; doi: 10.1039/C1NJ20489k.
21. Ziemba B, Janaszewska A, Ciepluch K, Krotewicz M, Fogel WA, Appelhans D, Voit B, Bryszewska M, Klajnert B. In vivo toxicity of poly (propyleneimine) dendrimers. J Biomed Mater Res Part A 2011;99A: 261-268.
22. Domanski DM, Klajnert B, Bryszewska M. Influence of PAMAM dendrimers on human red blood cells. Bioelectrochemistry 2004;63:189-191. (Pubitemid 38534218)
23. Mishra V, Gupta U, Jain NK. Influence of different generations of poly (propylene imine) dendrimers on human erythrocytes. Pharmazie 2010;65:891-895.
24. Klajnert B, Janiszewska J, Urbanczyk-Lipkowska Z, Bryszewska M, Shcharbin D, Labieniec M. Biological properties of low molecular mass peptide dendrimers. Int J Pharm 2006;309:208-217. (Pubitemid 43129484)
25. Ziemba B, Matuszko G, Bryszewska M, Klajnert B. Influence of dendrimers on red blood cells. Cell Mol Biol Lett 2012;17:21-35.
26. Han MH, Chen J, Wang J, Chen SL, Wang XT. Blood compatibility of polyamidoamine dendrimers and erythrocyte protection. J Biomed Nanotechnol 2010;6:82-92.
27. Kim Y, Hechler B, Klutz AM, Gachet C, Jacobson KA. Toward multivalent signaling across G protein-coupled receptors from poly (amidoamine) dendrimers. Bioconjug Chem 2008;19:406-411. (Pubitemid 351294910)
28. Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, De Paoli Lacerda SH, McNeil SE. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm 2012;9:382-393.
29. Portevin D, Poupot M, Rolland O, Turrin CO, Fournié JJ, Majoral JP, Caminade AM, Poupot R. Regulatory activity of azabisphosphonatecapped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy. J Transl Med 2009;7:82-94.
30. Sheng KC, Kalkanidis M, Pouniotis DS, Esparon S, Tang CK, Apostolopoulos V, Pietersz GA. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur J Immunol 2008;38:424-436.
31. Bermejo JF, Ortega P, Chonco L, Eritja R, Samaniego R, Müllner M, de Jesus E, de la Mata FJ, Flores JC, Gomez R, Muñoz-Fernandez A. Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. Chemistry 2007;13:483-495. (Pubitemid 46104695)
32. Köth A, Appelhans D, Tiersch B, Koetz J. Use of weakly cationic gendritic glycopolymer for morphological transformation of phospholipid vesicles into tube-like network. Soft Matter 2011;7:10581-10584.
33. Appelhans D, Oertel U, Mazzeo R, Komber H, Hoffmann J, Weidner S, Brutschy B, Voit B, Ottaviani MF. Dense-shell glycodendrimers: UV/Vis and electron paramagnetic resonance study of metal ion complexation. Proc R Soc A 2010;466:1489-1513.
34. Mkandawire M, Pohl A, Gubarevich T, Lapina V, Appelhans D, Rödel G, Pompe W, Schreiber J, Opitz J. Selective targeting of green fluorescent nanodiamond conjugates to mitochondria in HeLa cells. J Biophoton 2009;2:596-606.
35. Ben-Ami R, Barshtein G, Mardi T, Deutch V, Elkayam O, Yedgar S, Berliner S. A synergistic effect of albumin and fibrinogen on immunoglobulininduced red blood cell aggregation. Am J Physiol Heart Circ Physiol 2003;285:H2663-H2669. (Pubitemid 37443087)
36. Klajnert B, Stanislawska L, Bryszewska M, Palecz B. Interactions between PAMAM dendrimers and bovine serum albumin. Biochim Biophys Acta 2003;1648:115-126. (Pubitemid 38234613)
37. Dobrovolskaia MA, Potter TM, Skoczen SL. Lymphocyte Proliferation Assay (ITA-6). NCL Assay Protocols, 2005. Frederick, MD: National Cancer Institute at Frederick; 2010. p 10.
38. Samal AB, Loiko EN. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level. Biochemistry (Mosc). 2000;65:230-236.
39. Mazhul V, Chernovets T, Zaitseva E, Shcharbin D. Slow internal dynamics of membrane proteins in mechanisms of proteaseinduced aggregation of platelets. Cell Biol Int 2003;27:571-578. (Pubitemid 36808676)
40. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and haemolysis. Biomaterials 2003;24:1121-1131. (Pubitemid 36069121)
41. Mecke A, Uppuluri S, Sassanella TM, Lee DK, Ramamoorthy A, Baker JR, Jr, Orr BG, Banaszak Holl MM. Direct observation of lipid bilayer disruption by poly (amidoamine) dendrimers. Chem Phys Lipids 2004;132:3-14. (Pubitemid 39458316)
42. Zhang TL, Gao YX, Lu JF, Wang K. Arsenite, arsenate and vanadate affect human erythrocyte membrane. J Inorg Biochem 2000;79:195-203. (Pubitemid 30628731)
43. Bessis M. Red cell shapes: an illustrated classification and its rationale. In: Bessis M, Wed RI, LeBond PF, editors. Red Cell Shapes. New York: Springer; 1973. p 1-23.
44. Sheetz P, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 1974;71:4457-4461.
45. Domanski DM, Bryszewska M, Salamonczyk G. Preliminary evaluation of the behavior of fifth-generation thiophosphate dendrimer in biological systems. Biomacromolecules 2004;5:2007-2012. (Pubitemid 39335243)
46. Klajnert B, Bryszewska M. Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin. Bioelectrochemistry 2002;55:33-35. (Pubitemid 34084746)
47. Shcharbin D, Janicka M, Wasiak M, Palecz B, Przybyszewska M, Zaborski M, Bryszewska M. Serum albumins have five sites for binding of cationic dendrimers. Biochim Biophys Acta 2007;1774:946-961.
48. Klajnert B, Pikala S, Bryszewska M. Haemolytic activity of polyamidoamine dendrimers and the protective role of human serum albumin. Proc R Soc A 2010;466:1527-1534.
49. Singh P, Gupta U, Asthana A, Jain NK. Folate and folate-PEGPAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug Chem 2008;19:2239-2252.
50. Wang Y, Guo R, Cao X, Shen M, Shi X. Encapsulation of 2-methoxyestradiol within multifunctional poly (amidoamine) dendrimers for targeted cancer therapy. Biomaterials 2011;32:3322-3329.
51. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251. (Pubitemid 24046687)
52. Kozar K, Zagozdzon R. Lymphocytes activation. In: Glab J, Jakobisiak M, Lasek W, editors. Immunology. Warsaw: PWN; 2006. p 176.
53. Omidi Y, Hollins AJ, Drayton RM, Akhtar S. Polypropylenimine dendrimer-induced gene expression changes: The effect of complexation with DNA, dendrimer generation and cell type. J Drug Target 2005;13:431-443. (Pubitemid 43084544)
54. Mukherjee SP, Lyng FM, Garcia A, Davoren M, Byrne HJ. Mechanistic studies of in vitro cytotoxicity of poly (amidoamine) dendrimers in mammalian cells. Toxicol Appl Pharmacol 2010;248:259-268.
55. Froehlich E, Mandeville JS, Weinert CM, Kreplak L. Bundling and aggregation of DNA by cationic dendrimers. Biomacromolecules 2011;12:511-517.
56. Ziemba B, Matuszko G, Appelhans D, Voit B, Bryszewska M, Klajnert B. Genotoxicity of PPI dendrimers. Biopolymers. Forthcoming. DOI: 10.1002/bip. 22056.
57. Mestel DS, Assaf C, Steinhoff M, Beyer M, Moebs M, Sterry W. Emerging drugs in cutaneous T cell lymphoma. Expert Opin Emerg Drugs 2008;13:345-361. (Pubitemid 351958442)
58. Rumbaut RE, Thiagarajan P. General characteristics of platelets. In: Rumbaut RE, Thiagarajan P, editors. Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis. San Rafael (CA): Morgan & Claypool Life Sciences; 2010. p 3-12.
59. Rumbaut RE, Thiagarajan P. Platelet adhesion to vascular walls. In: Rumbaut RE, Thiagarajan P, editors. Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis. San Rafael (CA): Morgan & Claypool Life Sciences; 2010. p 13-20.
60. Watson SP, Authi KS. Platelets: a practical approach. Oxford: IRL Press at Oxford University Press; 1996. p 370.
61. Jakubowski JA. Beyond platelet functional testing: value in the aggregate. Biomark Med 2011;5:5-8.
62. von Lewinski F, Riggert J, Paulus W. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis. J Stroke Cerebrovasc Dis 2009;18:111-115.
63. Kottke-Marchant K. Importance of platelets and platelet response in acute coronary syndromes. Cleve Clin J Med 2009;76(Suppl 1):S2-S7.
64. Pearlstein E, Salko PL, Yogeeswaran G, Karpatkin S. Correlation between spontaneous metastatic potential, platelet-Aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line (Wistar-Furth rats/polyoma-induced PW20 tumor/platelet). Proc Natl Acad Sci USA 1980;77:4336-4339. (Pubitemid 10022606)
65. Landolfi R, De Cristofaro R, De Candia E, Rocca B, Bizzi B. Effect of fibrinogen concentration on the velocity of platelet aggregation. Blood 1991;78:377-381.
66. Marincu BN, Neagu M, Munteanu O, Neagu A. Kinetic study of platelet aggregation. Romanian J Biophys 2010;20:101-114.